Maglack (Magnesium Aspartate Dihydrate, Magnesium Citrate)

Both magnesium aspartate and magnesium citrate release magnesium ions after oral ingestion. These ions act as essential cofactors for numerous enzymatic processes, aid in ATP production, regulate ion channels, and support neuromuscular transmission and vascular tone, thereby contributing to overall cellular function.

The appropriate dose of Maglack is determined by the prescribing healthcare professional based on the individual’s age, clinical condition, dietary intake, and laboratory results. Patients should follow the prescriber’s instructions and not exceed the recommended amount without medical guidance.

Safety data for Maglack in pregnancy and lactation are limited. Women who are pregnant, planning to become pregnant, or breastfeeding should discuss potential benefits and risks with their healthcare provider before starting the supplement.

To order Maglack, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Maglack combines magnesium aspartate dihydrate and magnesium citrate, offering both high bioavailability and a balanced ionic profile. Compared with single‑salt products, this combination may provide more consistent absorption and broader support for enzymatic functions, though individual response can vary.

Store Maglack at ambient temperature, preferably below 25 °C, in its original packaging. Keep the container tightly closed, protect it from moisture, direct sunlight and extreme heat to maintain product stability.

Maglack is taken orally, usually with water. It can be consumed with or without food, but patients should follow the prescriber’s guidance regarding timing and whether to take it with meals to minimize gastrointestinal discomfort.

The most serious risks include hypermagnesemia, which can lead to cardiac arrhythmias, severe hypotension, and allergic reactions such as rash, swelling or anaphylaxis. These events are rare and typically occur with excessive dosing or in patients with renal impairment.

Individuals with severe renal failure, known hypersensitivity to magnesium salts, or those already receiving high‑dose magnesium therapy should avoid Maglack unless directed by a physician. Patients on medications that interact significantly with magnesium should also seek medical advice before use.